These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 23883124)

  • 1. Oligonucleotide conjugates for therapeutic applications.
    Winkler J
    Ther Deliv; 2013 Jul; 4(7):791-809. PubMed ID: 23883124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covalent conjugation of oligonucleotides with cell-targeting ligands.
    Alam MR; Ming X; Nakagawa O; Jin J; Juliano RL
    Bioorg Med Chem; 2013 Oct; 21(20):6217-23. PubMed ID: 23777829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragment-based solid-phase assembly of oligonucleotide conjugates with peptide and polyethylene glycol ligands.
    Dirin M; Urban E; Noe CR; Winkler J
    Eur J Med Chem; 2016 Oct; 121():132-142. PubMed ID: 27236069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current progress on aptamer-targeted oligonucleotide therapeutics.
    Dassie JP; Giangrande PH
    Ther Deliv; 2013 Dec; 4(12):1527-46. PubMed ID: 24304250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concise postsynthetic preparation of oligonucleotide-oligopeptide conjugates through facile disulfide bond formation.
    Dirin M; Urban E; Lachmann B; Noe CR; Winkler J
    Future Med Chem; 2015; 7(13):1657-73. PubMed ID: 26381134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convenient Solid-Phase Attachment of Small-Molecule Ligands to Oligonucleotides via a Biodegradable Acid-Labile P-N-Bond.
    Kropacheva NO; Golyshkin AA; Vorobyeva MA; Meschaninova MI
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioconjugates for targeted delivery of therapeutic oligonucleotides.
    Ming X; Laing B
    Adv Drug Deliv Rev; 2015 Jun; 87():81-9. PubMed ID: 25689735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligonucleotide delivery: a patent review (2010 - 2013).
    Grijalvo S; Aviñó A; Eritja R
    Expert Opin Ther Pat; 2014 Jul; 24(7):801-19. PubMed ID: 24798406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of Cancer Cell-Specific Aptamers in Targeted Delivery of Anticancer Therapeutic Agents.
    Kim M; Kim DM; Kim KS; Jung W; Kim DE
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29617327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-L-selectin aptamers: binding characteristics, pharmacokinetic parameters, and activity against an intravascular target in vivo.
    Watson SR; Chang YF; O'Connell D; Weigand L; Ringquist S; Parma DH
    Antisense Nucleic Acid Drug Dev; 2000 Apr; 10(2):63-75. PubMed ID: 10805157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Floxuridine Oligonucleotide Conjugates Carrying Potential Enhancers of Cellular Uptake.
    Aviñó A; Clua A; Bleda MJ; Eritja R; Fàbrega C
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical strategies for the synthesis of peptide-oligonucleotide conjugates.
    Lu K; Duan QP; Ma L; Zhao DX
    Bioconjug Chem; 2010 Feb; 21(2):187-202. PubMed ID: 19856957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent preclinical and clinical advances in oligonucleotide conjugates.
    Craig K; Abrams M; Amiji M
    Expert Opin Drug Deliv; 2018 Jun; 15(6):629-640. PubMed ID: 29727206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid-phase synthesis of oligonucleotide conjugates useful for delivery and targeting of potential nucleic acid therapeutics.
    Lönnberg H
    Bioconjug Chem; 2009 Jun; 20(6):1065-94. PubMed ID: 19175328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronan-based delivery of therapeutic oligonucleotides for treatment of human diseases.
    Ossipov DA
    Expert Opin Drug Deliv; 2019 Jun; 16(6):621-637. PubMed ID: 31072142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smart functional nucleic acid chimeras: enabling tissue specific RNA targeting therapy.
    Aaldering LJ; Tayeb H; Krishnan S; Fletcher S; Wilton SD; Veedu RN
    RNA Biol; 2015; 12(4):412-25. PubMed ID: 25849197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and applications of oligonucleotide-carbohydrate conjugates.
    Zatsepin TS; Oretskaya TS
    Chem Biodivers; 2004 Oct; 1(10):1401-17. PubMed ID: 17191787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular Targeting of Oligonucleotides by Conjugation with Small Molecules.
    Hawner M; Ducho C
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33339365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chemistry and biology of oligonucleotide conjugates.
    Juliano RL; Ming X; Nakagawa O
    Acc Chem Res; 2012 Jul; 45(7):1067-76. PubMed ID: 22353142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyamine-oligonucleotide conjugates: a promising direction for nucleic acid tools and therapeutics.
    Menzi M; Lightfoot HL; Hall J
    Future Med Chem; 2015; 7(13):1733-49. PubMed ID: 26424049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.